OBJECTIVES: To evaluate readmission rates and associated factors to identify potentially preventable readmissions. BACKGROUND: The decision to penalize hospitals for readmissions is compelling health care systems to develop processes to minimize readmissions. Research to identify preventable readmissions is critical to achieve these goals. METHODS: We performed a retrospective review of University HealthSystem Consortium database for cancer patients hospitalized from January 2010 to September 2013. Outcome measures were 7-, 14-, and 30-day readmission rates and readmission diagnoses. Hospital and disease characteristics were evaluated to evaluate relationships with readmission. RESULTS: A total of 2,517,886 patients were hospitalized for cancer treatment. Readmission rates at 7, 14, and 30 days were 2.2%, 3.7%, and 5.6%, respectively. Despite concern that premature hospital discharge may be associated with increased readmissions, a shorter initial length of stay predicted lower readmission rates. Furthermore, high-volume centers and designated cancer centers had higher readmission rates. Evaluating institutional data (N = 2517 patients) demonstrated that factors associated with higher readmission rates include discharge from a medical service, site of malignancy, and emergency primary admission. When examining readmission within 7 days for surgical services, the most common readmission diagnoses were infectious causes (46.3%), nausea/vomiting/dehydration (26.8%), and pain (6.1%). CONCLUSIONS: A minority of patients after hospitalization for cancer-related therapy are readmitted with potentially preventable conditions such as nausea, vomiting, dehydration, and pain. However, most factors associated with readmission cannot be modified. In addition, high-volume centers and designated cancer centers have higher readmission rates, which may indicate that readmission rates may not be an appropriate marker for quality improvement.
OBJECTIVES: To evaluate readmission rates and associated factors to identify potentially preventable readmissions. BACKGROUND: The decision to penalize hospitals for readmissions is compelling health care systems to develop processes to minimize readmissions. Research to identify preventable readmissions is critical to achieve these goals. METHODS: We performed a retrospective review of University HealthSystem Consortium database for cancerpatients hospitalized from January 2010 to September 2013. Outcome measures were 7-, 14-, and 30-day readmission rates and readmission diagnoses. Hospital and disease characteristics were evaluated to evaluate relationships with readmission. RESULTS: A total of 2,517,886 patients were hospitalized for cancer treatment. Readmission rates at 7, 14, and 30 days were 2.2%, 3.7%, and 5.6%, respectively. Despite concern that premature hospital discharge may be associated with increased readmissions, a shorter initial length of stay predicted lower readmission rates. Furthermore, high-volume centers and designated cancer centers had higher readmission rates. Evaluating institutional data (N = 2517 patients) demonstrated that factors associated with higher readmission rates include discharge from a medical service, site of malignancy, and emergency primary admission. When examining readmission within 7 days for surgical services, the most common readmission diagnoses were infectious causes (46.3%), nausea/vomiting/dehydration (26.8%), and pain (6.1%). CONCLUSIONS: A minority of patients after hospitalization for cancer-related therapy are readmitted with potentially preventable conditions such as nausea, vomiting, dehydration, and pain. However, most factors associated with readmission cannot be modified. In addition, high-volume centers and designated cancer centers have higher readmission rates, which may indicate that readmission rates may not be an appropriate marker for quality improvement.
Authors: Dawn M Emick; Taylor S Riall; John L Cameron; Jordan M Winter; Keith D Lillemoe; Joann Coleman; Patricia K Sauter; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-11 Impact factor: 3.452
Authors: David Yu Greenblatt; Sharon M Weber; Erin S O'Connor; Noelle K LoConte; Jinn-Ing Liou; Maureen A Smith Journal: Ann Surg Date: 2010-04 Impact factor: 12.969
Authors: G A Porter; P W Pisters; C Mansyur; A Bisanz; K Reyna; P Stanford; J E Lee; D B Evans Journal: Ann Surg Oncol Date: 2000-08 Impact factor: 5.344
Authors: Mark R Hemmila; Jill L Jakubus; Paul M Maggio; Wendy L Wahl; Justin B Dimick; Darrell A Campbell; Paul A Taheri Journal: Surgery Date: 2008-08 Impact factor: 3.982
Authors: Deepthi M Reddy; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin; Taylor S Riall Journal: J Gastrointest Surg Date: 2009-09-16 Impact factor: 3.452
Authors: Kristoffer W Brudvik; Yoshihiro Mise; Claudius Conrad; Giuseppe Zimmitti; Thomas A Aloia; Jean-Nicolas Vauthey Journal: J Am Coll Surg Date: 2015-02-28 Impact factor: 6.113
Authors: Deniz Can Guven; Furkan Ceylan; Ibrahim Yahya Cakir; Engin Cesmeci; Basak Sayinalp; Berkay Yesilyurt; Gurkan Guner; Hasan Cagri Yildirim; Oktay Halit Aktepe; Zafer Arik; Alev Turker; Omer Dizdar Journal: Support Care Cancer Date: 2021-01-06 Impact factor: 3.603
Authors: Rebecca S Lash; Janice F Bell; Sarah C Reed; Hermine Poghosyan; James Rodgers; Katherine K Kim; Richard J Bold; Jill G Joseph Journal: Cancer Nurs Date: 2017 Mar/Apr Impact factor: 2.592
Authors: Chaoyi Zheng; Elizabeth B Habermann; Nawar M Shara; Russell C Langan; Young Hong; Lynt B Johnson; Waddah B Al-Refaie Journal: J Am Coll Surg Date: 2016-02-05 Impact factor: 6.113
Authors: Varun Puri; Aalok P Patel; Traves D Crabtree; Jennifer M Bell; Stephen R Broderick; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers Journal: J Thorac Cardiovasc Surg Date: 2015-08-28 Impact factor: 5.209
Authors: Kathryn H Bowles; Christopher M Murtaugh; Lizeyka Jordan; Yolanda Barrón; Mark E Mikkelsen; Christina R Whitehouse; Jo-Ana D Chase; Miriam Ryvicker; Penny Hollander Feldman Journal: J Am Med Dir Assoc Date: 2019-12-16 Impact factor: 4.669